Repurposing Drugs in the Genomics Era: Bioinformatics Approaches
Open Access
- 3 May 2016
- journal article
- Published by MedCrave Group Kft. in MOJ Proteomics & Bioinformatics
- Vol. 3 (4) , 1-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Repurposing Drugs to Target the Diabetes EpidemicTrends in Pharmacological Sciences, 2016
- MalaCards: A Comprehensive Automatically‐Mined Database of Human DiseasesCurrent Protocols in Bioinformatics, 2014
- A draft map of the human proteomeNature, 2014
- Mass-spectrometry-based draft of the human proteomeNature, 2014
- Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugsEmerging Microbes & Infections, 2014
- Phenotype–Genotype Integrator (PheGenI): synthesizing genome-wide association study (GWAS) data with existing genomic resourcesEuropean Journal of Human Genetics, 2013
- In silico drug repositioning – what we need to knowDrug Discovery Today, 2013
- Predicting New Indications for Approved Drugs Using a Proteochemometric MethodJournal of Medicinal Chemistry, 2012
- Towards a knowledge-based Human Protein AtlasNature Biotechnology, 2010
- Trends in Risks Associated With New Drug Development: Success Rates for Investigational DrugsClinical Pharmacology & Therapeutics, 2010